Brigid G. Hill, MSc, University of Otago, Otago, New Zealand
Introduction: An endoleak can occur following endovascular aortic aneurysm repair (EVAR). In Otago post-EVAR ultrasound imaging occurs at 1, 6, and 12 months, followed by life-long annual surveillance. Recent guidelines have proposed a less intensive regime: surveillance at 5 years if an endoleak was absent at the first follow-up. This audit was conducted to determine the timing and occurrence of endoleaks in our cohort as per our current surveillance protocol to guide the development of future guidelines for the New Zealand population.
Methods: A single-center retrospective audit of the post-EVAR ultrasound surveillance regime was conducted, including all records from 2008 to January 2023. General characteristics were obtained from patient records. Duplex ultrasound images were used to determine the timing and type of endoleak, with measurements of aortic sac size recorded at each visit. Descriptive data are shown with continuous data shown as mean (95% confidence interval (CI)).
Results: The cohort consisted of 342 patients (83% male) with >60% with 1+ risk factors (eg, smoking, dyslipidemia, and hypertension) with EVAR conducted at 77 years of age (76.1-77.7). At the database interrogation date, 170/342 remain under surveillance with all-cause mortality or frailty as the major reason for loss to follow-up between 4 and 5 years post-EVAR. Endoleak was detected in 43.3% of patients, with 18.3%, 73.7%, 6.9%, and 1.1% Type 1, 2, 3, and 4/5 endoleak, respectively, and categorized into early (initial scheduled scan) or late (at/after 6-month scan). On average, an endoleak was detected at 2.2 (1.7-2.6) years post-EVAR. Scans conducted between 0.5 and <5 years detected an endoleak, 81% type 1 (a or b), and approximately 28% significant type 2.
Discussion and Conclusion: Our audit data show that the proposed modified surveillance regime would result in a missed opportunity to identify many occurrences of clinically significant endoleak in our Otago Vascular Diagnostic post-EVAR cohort, including approximately 41% of endoleaks clinically deemed to require intervention.